Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. DOPTELET (avatrombopag)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

DOPTELET (avatrombopag)

Medicine - Posted on Sep 30 2021
Active substance (DCI)
  • avatrombopag
history (2)
  • 9/8/21

    DOPTELET 20 mg (avatrombopag)

    Key points Unfavourable opinion for reimbursement in the treatment of primary chronic immune thrombocytopenia (ITP) in adult...
    CAV :
    54321
    icône flèche
  • 1/20/21

    DOPTELET (avatrombopag)

    Key points Unfavourable opinion for reimbursement in the treatment of severe thrombocytopenia in adult patients with chronic...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • B02BX08
Manufacturer
SWEDISH ORPHAN BIOVITRUM
Presentation

DOPTELET 20 mg, comprimé pelliculé
Boite de 10 comprimés (CIP : 34009 302 094 6 2)
Boite de 15 comprimés (CIP : 34009 302 094 7 9)

All our publications
    Blood and lymphatic diseases Blood and lymphatic diseases - miscellaneous Drug therapy Liver diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
FbjgWaC8j8tx8naL